| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.828 | 0.002 | 0.828 | Acetylcholine muscarinic antagonist | 0.765 0.002 DBMET02191 | ||
| 0.828 | 0.002 | 0.828 | Acetylcholine M2 receptor antagonist | 0.662 0.002 DBMET02191 | ||
| 0.811 | 0.003 | 0.811 | Acetylcholine antagonist | 0.73 0.003 DBMET02191 | ||
| 0.808 | 0.003 | 0.808 | Cholinergic antagonist | 0.733 0.003 DBMET02191 | ||
| 0.771 | 0.001 | 0.771 | Acetylcholine M3 receptor antagonist | 0.689 0.002 DBMET02191 | ||
| 0.636 | 0.014 | 0.672 | Toll-Like receptor 7 agonist | 0.672 0.01 DBMET02191 | DBMET02191 | |
| 0.631 | 0.014 | 0.666 | Toll-Like receptor agonist | 0.666 0.011 DBMET02191 | DBMET02191 | |
| 0.424 | 0.005 | 0.479 | Acetylcholine M1 receptor antagonist | 0.479 0.004 DBMET02191 | DBMET02191 | |
| 0.382 | 0.093 | 0.414 | Analgesic | 0.414 0.078 DBMET02191 | DBMET02191 | |
| 0.295 | 0.01 | 0.295 | Antihistaminic | 0.187 0.023 DBMET02191 | ||
| 0.293 | 0.01 | 0.293 | Histamine antagonist | 0.17 0.024 DBMET02191 | ||
| 0.272 | 0.024 | 0.272 | Cholinergic | 0.242 0.031 DBMET02191 | ||
| 0.26 | 0.014 | 0.26 | Butyrylcholinesterase inhibitor | 0.218 0.019 DBMET02191 | ||
| 0.247 | 0.021 | 0.247 | Acetylcholinesterase inhibitor | 0.224 0.027 DBMET02191 | ||
| 0.228 | 0.004 | 0.228 | Acetylcholine M5 receptor antagonist | 0.131 0.01 DBMET02191 | ||
| 0.216 | 0.025 | 0.216 | Histone deacetylase SIRT1 inhibitor | |||
| 0.226 | 0.054 | 0.226 | Sigma receptor agonist | 0.216 0.057 DBMET02191 | ||
| 0.241 | 0.071 | 0.241 | Potassium channel blocker | |||
| 0.2 | 0.032 | 0.227 | Anesthetic local | 0.227 0.025 DBMET02191 | DBMET02191 | |
| 0.168 | 0.006 | 0.168 | Histamine H3 receptor antagonist | |||
| 0.222 | 0.066 | 0.266 | Platelet aggregation inhibitor | 0.266 0.045 DBMET02191 | DBMET02191 | |
| 0.177 | 0.022 | 0.177 | Platelet activating factor alpha antagonist | 0.132 0.037 DBMET02191 | ||
| 0.259 | 0.119 | 0.323 | Sodium/bile acid cotransporter inhibitor | 0.323 0.059 DBMET02191 | DBMET02191 | |
| 0.218 | 0.084 | 0.218 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.139 | 0.006 | 0.139 | Neurokinin 2 antagonist | 0.107 0.009 DBMET02191 | ||
| 0.178 | 0.05 | 0.178 | Heat shock protein 90 antagonist | |||
| 0.213 | 0.088 | 0.213 | MAP kinase kinase 3 inhibitor | |||
| 0.22 | 0.105 | 0.32 | Spasmolytic | 0.32 0.063 DBMET02191 | DBMET02191 | |
| 0.154 | 0.04 | 0.154 | Histone deacetylase class III inhibitor | |||
| 0.116 | 0.005 | 0.116 | 5 Hydroxytryptamine 4 antagonist | 0.096 0.008 DBMET02191 | ||
| 0.228 | 0.137 | 0.228 | Ca(v)3.3 blocker | |||
| 0.093 | 0.005 | 0.093 | Beta 2 adrenoreceptor agonist | 0.093 0.005 DBMET02191 | ||
| 0.113 | 0.029 | 0.146 | Adrenaline agonist | 0.146 0.015 DBMET02191 | DBMET02191 | |
| 0.131 | 0.047 | 0.131 | Falcipain 3 inhibitor | 0.112 0.06 DBMET02191 | ||
| 0.147 | 0.072 | 0.186 | Hemostatic | 0.186 0.039 DBMET02191 | DBMET02191 | |
| 0.086 | 0.012 | 0.086 | Oleamide hydrolase inhibitor | |||
| 0.122 | 0.048 | 0.122 | Alpha 2c adrenoreceptor antagonist | |||
| 0.195 | 0.123 | 0.249 | Cardiotonic | 0.249 0.083 DBMET02191 | DBMET02191 | |
| 0.123 | 0.056 | 0.123 | Alpha 2b adrenoreceptor antagonist | |||
| 0.08 | 0.017 | 0.08 | Neurokinin antagonist | 0.055 0.029 DBMET02191 | ||
| 0.09 | 0.03 | 0.09 | Amidase inhibitor | |||
| 0.132 | 0.075 | 0.132 | Calcium channel blocker | 0.128 0.078 DBMET02191 | ||
| 0.072 | 0.015 | 0.072 | Chemokine receptor agonist | |||
| 0.091 | 0.037 | 0.091 | Analgesic, opioid | 0.086 0.041 DBMET02191 | ||
| 0.069 | 0.017 | 0.069 | CC chemokine 3 receptor antagonist | 0.063 0.019 DBMET02191 | ||
| 0.09 | 0.048 | 0.117 | Histamine H1 receptor antagonist | 0.117 0.033 DBMET02191 | DBMET02191 | |
| 0.084 | 0.042 | 0.084 | Viral attachment inhibitor | 0.081 0.048 DBMET02191 | ||
| 0.091 | 0.051 | 0.106 | Acetylcholine M3 receptor agonist | 0.106 0.042 DBMET02191 | DBMET02191 | |
| 0.069 | 0.029 | 0.069 | Histone deacetylase SIRT3 inhibitor | |||
| 0.054 | 0.014 | 0.054 | Substance P antagonist | 0.04 0.027 DBMET02191 | ||
| 0.198 | 0.16 | 0.198 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.158 | 0.123 | 0.158 | MAP kinase kinase 5 inhibitor | |||
| 0.064 | 0.031 | 0.064 | Acetylcholine muscarinic agonist | 0.048 0.046 DBMET02191 | ||
| 0.13 | 0.1 | 0.13 | Anticoagulant | 0.121 0.11 DBMET02191 | ||
| 0.155 | 0.125 | 0.155 | HERG channel blocker | |||
| 0.058 | 0.029 | 0.058 | Sigma receptor antagonist | 0.05 0.035 DBMET02191 | ||
| 0.104 | 0.076 | 0.104 | 5 Hydroxytryptamine antagonist | |||
| 0.117 | 0.091 | 0.117 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.047 | 0.021 | 0.047 | Neurokinin 1 antagonist | 0.037 0.034 DBMET02191 | ||
| 0.04 | 0.015 | 0.04 | CXC chemokine receptor agonist | |||
| 0.088 | 0.065 | 0.088 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | |||
| 0.08 | 0.058 | 0.08 | Opioid kappa receptor antagonist | |||
| 0.102 | 0.081 | 0.107 | Calcium channel (voltage-sensitive) blocker | 0.107 0.074 DBMET02191 | DBMET02191 | |
| 0.058 | 0.04 | 0.058 | Dopamine uptake inhibitor | |||
| 0.082 | 0.063 | 0.082 | Acetylcholine agonist | |||
| 0.072 | 0.053 | 0.072 | Histone deacetylase SIRT2 inhibitor | |||
| 0.046 | 0.03 | 0.052 | Beta adrenoreceptor agonist | 0.052 0.014 DBMET02191 | DBMET02191 | |
| 0.094 | 0.081 | 0.094 | DNA intercalator | 0.092 0.083 DBMET02191 | ||
| 0.095 | 0.083 | 0.095 | Platelet activating factor antagonist | |||
| 0.097 | 0.087 | 0.097 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.026 | 0.019 | 0.026 | Sigma 1 receptor antagonist | |||
| 0.193 | 0.186 | 0.193 | Ca2+/calmodulin-dependent kinase IV inhibitor | |||
| 0.024 | 0.019 | 0.024 | 5 Hydroxytryptamine 4 agonist | |||
| 0.038 | 0.034 | 0.038 | Acetylcholine M1 receptor agonist | |||
| 0.046 | 0.045 | 0.046 | Opioid agonist | |||
| 0.084 | 0.082 | 0.093 | Chemokine receptor antagonist | 0.093 0.071 DBMET02191 | DBMET02191 | |
| 0.031 | 0.031 | 0.032 | Leukotriene A4 hydrolase inhibitor | 0.032 0.031 DBMET02191 | DBMET02191 | |
| 0.063 | 0.065 | 0.071 | Epoxide hydrolase inhibitor | 0.071 0.052 DBMET02191 | DBMET02191 | |
| 0.03 | 0.038 | 0.032 | HCV polyprotein inhibitor | 0.032 0.029 DBMET02191 | DBMET02191 | |
| 0.187 | 0.195 | 0.313 | Antithrombotic | 0.313 0.08 DBMET02191 | DBMET02191 | |
| 0.257 | 0.276 | 0.281 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.281 0.239 DBMET02191 | DBMET02191 | |
| 0.08 | 0.118 | 0.103 | Alkylator | 0.103 0.085 DBMET02191 | DBMET02191 | |
| 0.038 | 0.084 | 0.052 | Autotaxin inhibitor | 0.052 0.038 DBMET02191 | DBMET02191 | |
| 0.071 | 0.127 | 0.099 | Chelator | 0.099 0.078 DBMET02191 | DBMET02191 | |
| 0.043 | 0.112 | 0.065 | CXC chemokine receptor antagonist | 0.065 0.058 DBMET02191 | DBMET02191 | |
| 0.112 | 0.199 | 0.188 | Platelet antagonist | 0.188 0.111 DBMET02191 | DBMET02191 | |
| 0.012 | 0.112 | 0.034 | CXC chemokine 3 receptor antagonist | 0.034 0.019 DBMET02191 | DBMET02191 | |
| 0.183 | 0.306 | 0.235 | Calcium channel L-type activator | 0.235 0.222 DBMET02191 | DBMET02191 | |
| 0.09 | 0.217 | 0.139 | DNA methylase inhibitor | 0.139 0.127 DBMET02191 | DBMET02191 | |
| 0.084 | 0.218 | 0.133 | Platelet adhesion inhibitor | 0.133 0.128 DBMET02191 | DBMET02191 | |
| 0.112 | 0.316 | 0.226 | Immunosuppressant | 0.226 0.17 DBMET02191 | DBMET02191 | |
| 0.018 | 0.239 | 0.035 | Glutamate (mGluR8) antagonist | 0.035 0.025 DBMET02191 | DBMET02191 | |
| 0.04 | 0.267 | 0.105 | AMP-activated protein kinase stimulant | 0.105 0.064 DBMET02191 | DBMET02191 | |
| 0.013 | 0.299 | 0.046 | Neuraminidase (Influenza A) inhibitor | 0.046 0.031 DBMET02191 | DBMET02191 | |
| 0.077 | 0.411 | 0.198 | Gastrin inhibitor | 0.198 0.152 DBMET02191 | DBMET02191 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |